In other words, CD27, EDA, TNF, TNFRSF12A, TNFRSF13C, and TNFRSF9 expression may also affect the immunotherapy effect on tumours by regulating the expression of immune checkpoint molecules in the tumour microenvironment. The gene discussed is TNFRSF9; the disease is neoplasm.